> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Compounding Beta-Lactam Products
- URL: https://www.fdaweb.com/guide-on-compounding-beta-lactam-products/
- Published: 2022-11-22T12:00:00.000Z
- Updated: 2026-09-14T18:07:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5153250

*Federal Register* notice: FDA is making available a final guidance entitled “Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the Federal Food, Drug, and Cosmetic Act.” The document describes FDA’s regulatory and enforcement priorities related to compounded beta-lactam oral antibiotic suspension products that appear on FDA’s drug shortage list by a licensed pharmacist. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-25622.pdf?ref=fdaweb.com).